PIGS expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.018800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.798400E-01
Normal-vs-Stage2
3.622600E-01
Normal-vs-Stage3
6.826200E-02
Normal-vs-Stage4
8.224400E-01
Stage1-vs-Stage2
9.698600E-01
Stage1-vs-Stage3
9.448200E-02
Stage1-vs-Stage4
2.324000E-01
Stage2-vs-Stage3
5.958400E-02
Stage2-vs-Stage4
1.656820E-01
Stage3-vs-Stage4
6.426300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.888000E-01
Normal-vs-AfricanAmerican
5.215000E-01
Normal-vs-Asian
3.299800E-01
Caucasian-vs-AfricanAmerican
5.605600E-01
Caucasian-vs-Asian
6.312000E-01
AfricanAmerican-vs-Asian
4.060800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.836400E-01
Normal-vs-Female
4.216000E-01
Male-vs-Female
9.704000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.117600E-01
Normal-vs-Age(41-60Yrs)
7.989200E-01
Normal-vs-Age(61-80Yrs)
2.649800E-01
Normal-vs-Age(81-100Yrs)
2.758400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.782200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.722000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.223200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.620300E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.320620E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.832400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.968210E-01
Normal-vs-Daily Drinker
2.403200E-01
Normal-vs-Weekly Drinker
3.565200E-01
Normal-vs-Occasional Drinker
6.888800E-01
Normal-vs-Social Drinker
5.714600E-01
Non Drinker-vs-Daily Drinker
4.902800E-01
Non Drinker-vs-Weekly Drinker
5.125600E-01
Non Drinker-vs-Occasional Drinker
1.257370E-03
Non Drinker-vs-Social Drinker
1.334770E-01
Daily Drinker-vs-Weekly Drinker
9.191600E-01
Daily Drinker-vs-Occasional Drinker
5.338700E-03
Daily Drinker-vs-Social Drinker
3.223200E-01
Weekly Drinker-vs-Occasional Drinker
2.700200E-02
Weekly Drinker-vs-Social Drinker
4.689400E-01
Occasional Drinker-vs-Social Drinker
1.014980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.108750E-01
Normal-vs-Grade 2
1.231860E-02
Normal-vs-Grade 3
3.955900E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.098600E-01
Grade 1-vs-Grade 3
1.941250E-01
Grade 1-vs-Grade 4
1.108750E-01
Grade 2-vs-Grade 3
1.080380E-01
Grade 2-vs-Grade 4
1.231860E-02
Grade 3-vs-Grade 4
3.955900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.380600E-01
Normal-vs-NonDiabetic
4.392000E-01
Diabetic-vs-NonDiabetic
2.499200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.291200E-01
Normal-vs-NoPancreatitis
3.802800E-01
Pancreatitis-vs-NoPancreatitis
1.993830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.472000E-01
Normal-vs-N1
3.602000E-01
N0-vs-N1
5.392400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.940000E-01
Normal-vs-TP53-NonMutant
5.134200E-01
TP53-Mutant-vs-TP53-NonMutant
4.801900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
